AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Continuous Renal Replacement Therapy

OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study NCT07419802n/a1 site๐Ÿ“ Riga Pauls Stradins Clinical University Hospital ยท Tests: AN69-polyethylenimine hemofilter (Oxirisยฎ) used for continuous veno-venous hemofiltration (CVVH) Analgesia Nociception Index to Explore Autonomic Nervous System in Patients With Continuous Renal Replacement Therapy NCT06285162n/a1 site๐Ÿ“ Bron Hospices Civils de Lyon Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy With oXiris Membrane NCT05575024n/a1 site๐Ÿ“ Seoul Seoul National University Hospital ยท Tests: oXiris membrane, Polysulfone membrane Standard Dose Continuous Renal Replacement Therapy (CRRT) Versus Low-Dose CRRT ( KETZEREI ) NCT06021288NA2 sites๐Ÿ“ Mรผnster๐Ÿ“ Tรผbingen Universitรคt Mรผnster ยท Tests: Effluent dose of CRRT Intra-Abdominal Pressure Changes During Continuous Renal Replacement Therapy in Critically Ill Patients NCT07823387n/a1 site๐Ÿ“ Bursa Bursa Yuksek Ihtisas Training and Research Hospital ยท Tests: Intravesical Intra-abdominal Pressure Measurement QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry NCT06517810n/a15 sites๐Ÿ“ Birmingham๐Ÿ“ Palo Alto๐Ÿ“ San Francisco SeaStar Medical ยท Tests: QUELIMMUNE (SCD-PED) Evaluation of Integrated Versus Parallel Connection for Renal Replacement Therapy in ECMO Patients NCT06038162NA12 sites๐Ÿ“ Bordeaux๐Ÿ“ Clermont-Ferrand๐Ÿ“ Dijon Hospices Civils de Lyon ยท Tests: Parallel connection, Integrated connection LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM) NCT06446739NA10 sites๐Ÿ“ Rochester๐Ÿ“ Calgary๐Ÿ“ Edmonton University of Alberta ยท Tests: Continuous Renal Replacement Therapy (CRRT) Effect of High Versus Standard Protein Intake in Critically Ill Patients With Acute Kidney Injury Requiring Continuous Renal Replacement Therapy NCT07596043NA1 site๐Ÿ“ Bangkok Chulalongkorn University ยท Tests: High protein group, Standard protein group Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator NCT06696235Phase 42 sites๐Ÿ“ Seoul๐Ÿ“ Seoul Samsung Medical Center ยท Tests: Early initiation of continuous renal replacement therapy, Standard initiation of continuous renal replacement therapy Early Endotoxin Burden Reduction With oXiris in Septic Shock Patients Requiring CRRT NCT07807410NA1 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: oXiris Hemofilter Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients NCT07643597n/a10 sites๐Ÿ“ Salvador๐Ÿ“ Concepciรณn๐Ÿ“ Los รngeles Hospital Las Higueras Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT NCT05399537Phase 314 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles Vantive Health LLC ยท Tests: Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department NCT07558265NA6 sites๐Ÿ“ Tucson๐Ÿ“ Ann Arbor๐Ÿ“ Columbus Ohio State University ยท Tests: Non-Invasive Positive Pressure Ventilation, High Flow Nasal Oxygen Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury NCT07236463Phase 1, Phase 22 sites๐Ÿ“ Nรฎmes๐Ÿ“ Nรฎmes Centre Hospitalier Universitaire de Nฤซmes ยท Tests: Continuous veino-veinous dialysis with iron-chelator supplemented dialysate Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patient NCT06369064NA1 site๐Ÿ“ Nรฎmes Centre Hospitalier Universitaire de Nฤซmes ยท Tests: CVVHD Dialysis parameters, CVVHDF Dialysis parameters Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagulants Using Calcium-containing Replacement Solutions NCT06021080n/a1 site๐Ÿ“ Fuzhou Fujian Provincial Hospital ยท Tests: CVVH, CVVHD Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children NCT04794595n/a1 site๐Ÿ“ Shanghai Children's Hospital of Fudan University ยท Tests: CBP Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients NCT06014801Phase 2, Phase 39 sites๐Ÿ“ Sendai๐Ÿ“ Takatsuki๐Ÿ“ Fukui Jikei University School of Medicine ยท Tests: Dialysate fluid, Filtration replacement fluid Optimization of Fluid Balance Guided by Bioelectrical Impedance Analysis in Patients Undergoing Continuous Renal Replacement Therapy in Critical Care NCT06799910NA1 site๐Ÿ“ Salouรซl Centre Hospitalier Universitaire, Amiens ยท Tests: continuous renal replacement therapy (CRRT), Free UF Prescription Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy NCT07346118NA2 sites๐Ÿ“ Bangkok๐Ÿ“ Bangkok Chulalongkorn University ยท Tests: mVExUS-guided fluid management Post-Filter Hematocrit NCT07293936NA1 site๐Ÿ“ Iowa City Gwyndolyn M. Radford ยท Tests: Calculated Post-Filter Hematocrit, Measured Post-Filter Hematocrit Nafamostat Efficacy in Phase 3 Registrational CRRT Study NCT06150742NA10 sites๐Ÿ“ Los Angeles๐Ÿ“ Orlando๐Ÿ“ Detroit Talphera, Inc ยท Tests: Niyad (nafamostat mesylate), Placebo (0.9% NaCl) Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU) NCT07469072Phase 21 site๐Ÿ“ Guangzhou Zhujiang Hospital ยท Tests: Nafamostat Low-Dose Group, Nafamostat High-Dose Group To Compare the Efficacy and Safety of Using oXiris and M100 During CRRT NCT06440759NA1 site๐Ÿ“ Kubang Kerian Mohd Zulfakar Mazlan, MBBS ยท Tests: oXiris filter, M100 filter WISDOM UK: Low Dose-intensity Versus Standard Dose-intensity CRRT in Critically Ill Patients NCT07447791NA1 site๐Ÿ“ London Guy's and St Thomas' NHS Foundation Trust ยท Tests: low intensity of CRRT, usual intensity of CRRT Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury NCT05758077NA36 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Los Angeles SeaStar Medical ยท Tests: Selective Cytopheretic Device, Standard of Care Filter Lifespan in Continuous Renal Replacement Therapy NCT05450185n/a5 sites๐Ÿ“ Innsbruck๐Ÿ“ Sรฃo Paulo๐Ÿ“ Erlangen University Hospital Muenster ยท Tests: Critically ill patients with continuous renal replacement therapy Amino Acid Loss During Continuous Renal Replacement Therapy NCT06659835n/a1 site๐Ÿ“ Vienna Medical University of Vienna Effect of a Furosemide Stress Test-Guided Strategy on Liberation From Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury NCT06229990Phase 41 site๐Ÿ“ Chiang Mai Chiang Mai University ยท Tests: Furosemide Injection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy